2020
-
Multidisciplinary approach needed to determine cardiac involvement in myositis and subsequent care
Cardiovascular disease is the dominant cause of mortality in myositis patients, accounting for up to 55% of deaths.
-
Patient self-management of disease requires better buy-in from care providers
Effective disease self-management for patients requires a patient-provider partnership, and an educational session at ACR Convergence 2020 offered practical steps for providers to encourage lupus patients to succeed at self-management.
-
New live Closing Session to feature crowdsourced highlights from ACR Convergence 2020
NBC News medical contributor Natalie Azar, MD, will interview Annual Meeting Planning Committee Basic Science and Clinical Chairs Gregg Silverman, MD, and Diane Kamen, MD, MSCR.
-
Rheumatologists have role to play in ensuring patients get the most out of immunotherapy
As use of immune checkpoint inhibitors increases, so does the number of patients experiencing rheumatologic immune-related adverse events.
-
Checkpoint inhibitors’ adverse events mimic rheumatic diseases
Checkpoint inhibitors have revolutionized the care of patients with certain cancers; however, patients treated with these therapies often develop immune-related adverse events that strongly resemble rheumatic autoimmune diseases.
-
Imaging interpretation critical in making correct axSpA diagnosis
Imaging plays a critical role in axial spondyloarthritis (axSpA) diagnosis, and three speakers will try to bring greater clarity to imaging issues during Controversies in the Diagnostic Evaluation of Axial Spondyloarthritis: An Experiential Review.
-
Expanding treatment options means comorbidities matter when selecting RA treatment
Faculty in How I Treat Difficult RA: Panel Session reviewed difficult-to-treat cases for RA patients with ILD, refractory RA, and RA with liver disease.
-
Panel discusses evolution, future considerations of SLE damage assessment index
Quantifying the severity of SLE damage remains a challenge, and an ACR Convergence 2020 session discussed issues pertaining to the development of an improved strategy.
-
Rheumatologists can lead their patients to reliable information in the digital world
As more and more patients with rheumatic diseases turn to the digital world for information and support, rheumatologists and their care teams need to know how to guide their patients toward reputable information and away from potentially harmful outcomes.
-
CCP arthritis remains under the radar, but research could lead to treatment breakthroughs
Calcium pyrophosphate (CCP) arthritis was first described more than 50 years ago. Since then, researchers have found that this extremely painful type of arthritis is extraordinarily common but significantly underdiagnosed.